HUALAN is pleased to announce the successful signing of a strategic equity investment agreement with Ningbo Guangfeng Capsule Co., Ltd. This milestone marks HUALAN’s official entry into the hollow capsule sector, a significant step in the company’s long-term strategy to provide integrated "Pharmaceutical Packaging + Excipients" solutions.

As critical components of drug delivery systems, hollow capsules and pharmaceutical rubber stoppers share a high degree of synergy in customer resources and technical compliance. By combining HUALAN’s established leadership in elastomeric closure technology with Guangfeng’s specialized capsule manufacturing expertise, the company aims to create a powerful industrial synergy. This integration will optimize product compatibility, streamline the supply chain for global pharmaceutical clients, and fortify HUALAN’s comprehensive Drug Delivery Systems ecosystem.

This investment aligns with HUALAN’s commitment to driving sustainable growth through portfolio diversification. Leveraging our robust quality management systems and extensive network of over 1,000 pharmaceutical partners, HUALAN is positioned to deliver enhanced value and innovative solutions to the global healthcare industry.